BioCentury
ARTICLE | Financial News

Trius raises $29.9 million in follow-on

January 19, 2013 1:08 AM UTC

Trius Therapeutics Inc. (NASDAQ:TSRX) raised $29.9 million through the sale of 6.3 million shares at $4.75 in a follow-on underwritten by Citigroup; Leerink; and Baird. Trius' tedizolid phosphate is i...